Up to 30 million individuals could lose Medicaid coverage; a new initiative demands increased focus on women's health issues; survey reports increased 5-year lung cancer survival rates from 2015 to 2019.
A report from Avalere reveals that up to 30 million of the most vulnerable Americans may lose Medicaid coverage due to flawed state reviews, with issues ranging from prolonged wait times in Florida to confusing paperwork in Arkansas, according to The Associated Press. Despite warnings from poverty experts, the Biden administration is accused of not effectively intervening. Advocates fear systemic problems are being ignored, pointing to procedural disenrollments, erroneous removals, and a lack of transparency in the reevaluation process.
The Biden administration, led by First Lady Jill Biden, is launching a new initiative to address the longstanding neglect of women's health in research, giving officials 45 days to propose specific actions for improvement, according to USA Today. Carolyn M. Mazure, PhD, a renowned expert in women's health from Yale University, will lead the initiative, focusing on critical areas such as heart attacks and menopause. Despite progress since the establishment of the National Institutes of Health's Office of Research on Women’s Health in 1990, significant gaps persist, with conditions like Alzheimer disease and heart disease disproportionately affecting women but receiving inadequate research funding.
A recent survey by the American Lung Association indicates a positive shift in lung cancer survival rates, particularly among historically marginalized communities, despite ongoing racial disparities in health care, according to NPR. The 5-year survival rate for lung cancer increased by 22% from 2015 to 2019, reaching 26.6% across all racial and ethnic groups. Notably, people of color experienced a 17% improvement in survival rates between 2017 and 2019, now standing at 23.7%. Despite the progress, disparities persist, with varying survival rates among different racial groups, highlighting the need for continued efforts to address health care inequities.
Neoadjuvant Chemotherapy Becomes Leading Initial Treatment for Advanced Epithelial Ovarian Cancer
October 22nd 2024By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for patients with advanced epithelial ovarian cancer, overtaking primary cytoreductive surgery.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen